SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-018011
Filing Date
2019-11-19
Accepted
2019-11-19 17:02:51
Documents
62
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 1506470
2 ex4-1.htm EX-4.1 169482
3 ex4-2.htm EX-4.2 119882
4 ex10-1.htm EX-10.1 274325
5 ex31-1.htm EX-31.1 18288
6 ex32-1.htm EX-32.1 8139
  Complete submission text file 0001493152-19-018011.txt   7814936

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE obmp-20190930.xml EX-101.INS 1140647
8 XBRL SCHEMA FILE obmp-20190930.xsd EX-101.SCH 72573
9 XBRL CALCULATION FILE obmp-20190930_cal.xml EX-101.CAL 55431
10 XBRL DEFINITION FILE obmp-20190930_def.xml EX-101.DEF 270469
11 XBRL LABEL FILE obmp-20190930_lab.xml EX-101.LAB 482861
12 XBRL PRESENTATION FILE obmp-20190930_pre.xml EX-101.PRE 347464
Mailing Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809
Business Address 11441 INDUSTRIPLEX BLVD SUITE 190 BATON ROUGE LA 70809 225-227-2384
OncBioMune Pharmaceuticals, Inc (Filer) CIK: 0001362703 (see all company filings)

IRS No.: 202590810 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-52218 | Film No.: 191231976
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences